Axena Health

Axena Health

Private
Newton, MassachusettsHealthcare & Life Scienceswww.axenahealth.com

Last Round

Early Stage

VC

Apr 14, 2026

Total Funding Raised

$34.4M

Company Overview

Axena Health is a healthcare technology company that provides an innovative platform for the non-invasive, drug-free treatment of urinary and chronic fecal incontinence, helping women improve their pelvic floor health through real-time movement visualization and progress monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement, Telemedicine

Business Model

B2B2C

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

pelvic healthFemtechurinary incontinence treatmentdigital therapeuticbiofeedback devicepelvic floor muscle trainingsmart Kegel trainerfecal incontinence treatmentwomen's health techprescription medical deviceat-home treatmentFDA-cleared devicemotion-based biofeedbacktelehealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axena Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Axena Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCApr 14, 2026
Series A ExtensionJun 4, 2024
Series AFeb 16, 2023

Key People

Founding team and executive leadership

Jim O'Connor

General Counsel Chief Financial Officer

Executive Team

Axena Health Investors

Notable investors and investment history

InvestorRounds
KOFA HealthcareSeries A Extension
AXA IM AltsSeries A Extension, Series A
Avestria VenturesSeries A Extension
Cross Border Impact VenturesSeries A Extension
AXA Investment ManagersSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    $15M raised in early stage VC funding.

  • Jan 14, 2026

    New AI solution for women with pelvic floor disorders.

Axena Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Axena Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Axena Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersNewton, Massachusetts
Employee Range48
Year Founded2023
Last FundingApr 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.